Highly effective for the treatment of urinary incontinence in both men and women, FDA-cleared EMSTRONG® now also holds an additional CE-mark certification for enhancing sexual function in patients experiencing somatic sexual arousal disorders caused by weak pelvic floor muscles.

“EMSTRONG continues to surpass expectations—not just for solving incontinence but for empowering confidence, and allowing patients to live life fully,” said Huapei Cai, President and General Manager of Rejuva Fresh Asia Pacific. “Clinical evidence and expanded regulatory clearances substantiate the real-world benefits practitioners and patients have consistently observed: EMSTRONG works effectively without invasive procedures, offering comfort and ease of use you can count on.”